Core Laboratories Inc [CLB] stock is trading at $24.35, up 10.58%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The CLB shares have gain 2.61% over the last week, with a monthly amount glided 25.39%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Core Laboratories Inc [NYSE: CLB] stock has seen the most recent analyst activity on June 30, 2023, when Citigroup downgraded its rating to a Sell and also revised its price target to $21 from $22. Previously, BofA Securities downgraded its rating to Underperform on April 18, 2023, and kept the price target unchanged to $21.50. On January 09, 2023, upgrade upgraded it’s rating to Neutral. Citigroup upgraded its rating to a Neutral and decreased its price target to $17 on October 07, 2022. Morgan Stanley downgraded its rating to a Underweight but $20 remained the price target by the analyst firm on September 26, 2022. Piper Sandler downgraded its rating to Underweight for this stock on April 18, 2022, and upped its price target to $21.30. In a note dated October 18, 2021, BofA Securities downgraded an Underperform rating on this stock and revised its target price from $36 to $32.
Core Laboratories Inc [CLB] stock has fluctuated between $13.82 and $27.94 over the past year. Currently, Wall Street analysts expect the stock to reach $25 within the next 12 months. Core Laboratories Inc [NYSE: CLB] shares were valued at $24.35 at the most recent close of the market. An investor can expect a potential return of 2.67% based on the average CLB price forecast.
Analyzing the CLB fundamentals
Core Laboratories Inc [NYSE:CLB] reported sales of 513.77M for the trailing twelve months, which represents a growth of 2.11%. Gross Profit Margin for this corporation currently stands at 0.18% with Operating Profit Margin at 0.1%, Pretax Profit Margin comes in at 0.08%, and Net Profit Margin reading is 0.05%. To continue investigating profitability, this company’s Return on Assets is posted at 0.05, Equity is 0.12 and Total Capital is 0.11. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.65.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 22.53 points at the first support level, and at 20.71 for the second support level. However, for the 1st resistance point, the stock is sitting at 25.35, and for the 2nd resistance point, it is at 26.36.
Ratios To Look Out For
For context, Core Laboratories Inc’s Current Ratio is 2.39. As well, the Quick Ratio is 1.68, while the Cash Ratio is 0.18. Considering the valuation of this stock, the price to sales ratio is 2.22, the price to book ratio is 4.64 and price to earnings (TTM) ratio is 41.48.
